MYELOMA ACTION MONTH Trademark

Trademark Overview


On Friday, April 11, 2025, a trademark application was filed for MYELOMA ACTION MONTH with the United States Patent and Trademark Office. The USPTO has given the MYELOMA ACTION MONTH trademark a serial number of 99133159. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, September 18, 2025. This trademark is owned by International Myeloma Foundation. The MYELOMA ACTION MONTH trademark is filed in the Advertising, Business and Retail Services category with the following description:

Association services, namely, promoting the public interest and awareness in cancer research and education; Association services, namely, promoting public awareness of myeloma research, diagnosis and treatment, and the need for access to a broad range of approved and medically-accepted anticancer regimens; Promoting public awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of of myeloma research, diagnosis and treatment; Promoting public awareness of the need for access to a broad range of approved and medically-accepted anticancer regimen by means of public advocacy
myeloma action month

General Information


Serial Number99133159
Word MarkMYELOMA ACTION MONTH
Filing DateFriday, April 11, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, September 18, 2025
Registration Number0000000
Registration DateTuesday, October 7, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAssociation services, namely, promoting the public interest and awareness in cancer research and education; Association services, namely, promoting public awareness of myeloma research, diagnosis and treatment, and the need for access to a broad range of approved and medically-accepted anticancer regimens; Promoting public awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of of myeloma research, diagnosis and treatment; Promoting public awareness of the need for access to a broad range of approved and medically-accepted anticancer regimen by means of public advocacy

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, April 11, 2025
Primary Code035
First Use Anywhere DateSaturday, February 1, 2025
First Use In Commerce DateSaturday, February 1, 2025

Trademark Owner History


Party NameInternational Myeloma Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStudio City, CA 91604

Trademark Events


Event DateEvent Description
Friday, April 11, 2025NEW APPLICATION ENTERED
Friday, April 11, 2025APPLICATION FILING RECEIPT MAILED
Monday, September 8, 2025ASSIGNED TO EXAMINER
Friday, July 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 8, 2025NON-FINAL ACTION WRITTEN
Tuesday, September 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 8, 2025NON-FINAL ACTION E-MAILED
Monday, September 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 10, 2025APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER